Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Bardwell HA"'
Autor:
Sammut SJ; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK.; Department of Oncology, University of Cambridge, Cambridge, UK.; CRUK Cambridge Centre, Cambridge Experimental Cancer Medicine Centre (ECMC) and NIHR Cambridge Biomedical Research Centre, University of Cambridge and Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Crispin-Ortuzar M; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK., Chin SF; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK., Provenzano E; CRUK Cambridge Centre, Cambridge Experimental Cancer Medicine Centre (ECMC) and NIHR Cambridge Biomedical Research Centre, University of Cambridge and Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Bardwell HA; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK., Ma W; School of Clinical Medicine, University of Cambridge, Cambridge, UK., Cope W; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK., Dariush A; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK.; Institute of Astronomy, University of Cambridge, Cambridge, UK., Dawson SJ; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Centre of Cancer Research and Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia., Abraham JE; Department of Oncology, University of Cambridge, Cambridge, UK.; CRUK Cambridge Centre, Cambridge Experimental Cancer Medicine Centre (ECMC) and NIHR Cambridge Biomedical Research Centre, University of Cambridge and Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Dunn J; Warwick Clinical Trials Unit, University of Warwick, Coventry, UK., Hiller L; Warwick Clinical Trials Unit, University of Warwick, Coventry, UK., Thomas J; Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh, UK.; Q2 Laboratory Solutions, Livingston, UK., Cameron DA; Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh, UK., Bartlett JMS; Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh, UK.; Ontario Institute for Cancer Research, Toronto, Ontario, Canada.; Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada., Hayward L; Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh, UK., Pharoah PD; CRUK Cambridge Centre, Cambridge Experimental Cancer Medicine Centre (ECMC) and NIHR Cambridge Biomedical Research Centre, University of Cambridge and Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.; Strangeways Research Laboratory, University of Cambridge, Cambridge, UK., Markowetz F; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK., Rueda OM; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK.; MRC Biostatistics Unit, University of Cambridge, Cambridge, UK., Earl HM; Department of Oncology, University of Cambridge, Cambridge, UK.; CRUK Cambridge Centre, Cambridge Experimental Cancer Medicine Centre (ECMC) and NIHR Cambridge Biomedical Research Centre, University of Cambridge and Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Caldas C; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK. carlos.caldas@cruk.cam.ac.uk.; Department of Oncology, University of Cambridge, Cambridge, UK. carlos.caldas@cruk.cam.ac.uk.; CRUK Cambridge Centre, Cambridge Experimental Cancer Medicine Centre (ECMC) and NIHR Cambridge Biomedical Research Centre, University of Cambridge and Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. carlos.caldas@cruk.cam.ac.uk.
Publikováno v:
Nature [Nature] 2022 Jan; Vol. 601 (7894), pp. 623-629. Date of Electronic Publication: 2021 Dec 07.
Autor:
Chin SF; Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK; Department of Oncology, University of Cambridge, Cambridge CB2 2QQ, UK; Cancer Research UK Cambridge Cancer Centre, Cambridge CB2 0QQ, UK. Electronic address: suet-feung.chin@cruk.cam.ac.uk., Santonja A; Medical Oncology Service, Hospital Universitario Regional y Virgen de la Victoria, Instituto de Investigación Biomédica de Málaga (IBIMA), Málaga, Spain; Laboratorio de Biología Molecular del Cáncer, Centro de Investigaciones Médico-Sanitarias (CIMES), Universidad de Málaga, Málaga, Spain., Grzelak M; Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK., Ahn S; Department of Pathology, Seoul National University Bundang Hospital, 82, Gumi-ro 173 Beon-gil, Bundang-gu, Seongnam, Gyeonggi 13620, Republic of Korea; Inivata, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK., Sammut SJ; Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK; Department of Oncology, University of Cambridge, Cambridge CB2 2QQ, UK; Cancer Research UK Cambridge Cancer Centre, Cambridge CB2 0QQ, UK., Clifford H; Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK., Rueda OM; Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK; Cancer Research UK Cambridge Cancer Centre, Cambridge CB2 0QQ, UK., Pugh M; Inivata UK, The Portway Building, Granta Park, Cambridge CB21 6GS, UK., Goldgraben MA; Department of Medical Genetics, University of Cambridge, Cambridge CB2 0QQ, UK., Bardwell HA; Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK., Cho EY; Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50 Irwon-dong, Gangnam-gu, Seoul 135-710, Republic of Korea., Provenzano E; Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust, NIHR Cambridge Biomedical Research Centre, Cambridge CB2 2QQ, UK; Cancer Research UK Cambridge Cancer Centre, Cambridge CB2 0QQ, UK., Rojo F; Pathology Department, Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD), Madrid, Spain; GEICAM-Spanish Breast Cancer Research Group, Madrid, Spain., Alba E; Medical Oncology Service, Hospital Universitario Regional y Virgen de la Victoria, Instituto de Investigación Biomédica de Málaga (IBIMA), Málaga, Spain; GEICAM-Spanish Breast Cancer Research Group, Madrid, Spain; Laboratorio de Biología Molecular del Cáncer, Centro de Investigaciones Médico-Sanitarias (CIMES), Universidad de Málaga, Málaga, Spain., Caldas C; Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK; Department of Oncology, University of Cambridge, Cambridge CB2 2QQ, UK; Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust, NIHR Cambridge Biomedical Research Centre, Cambridge CB2 2QQ, UK; Cancer Research UK Cambridge Cancer Centre, Cambridge CB2 0QQ, UK. Electronic address: carlos.caldas@cruk.cam.ac.uk.
Publikováno v:
Experimental and molecular pathology [Exp Mol Pathol] 2018 Jun; Vol. 104 (3), pp. 161-169. Date of Electronic Publication: 2018 Mar 31.
Autor:
Li B; UCD School of Biomolecular and Biomedical Science, UCD Conway Institute, University College Dublin, Dublin, Ireland., Ni Chonghaile T; Department of Physiology & Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland., Fan Y; UCD School of Biomolecular and Biomedical Science, UCD Conway Institute, University College Dublin, Dublin, Ireland., Madden SF; Population Health Sciences Division, Royal College of Surgeons in Ireland, Dublin, Ireland., Klinger R; UCD School of Biomolecular and Biomedical Science, UCD Conway Institute, University College Dublin, Dublin, Ireland., O'Connor AE; UCD School of Biomolecular and Biomedical Science, UCD Conway Institute, University College Dublin, Dublin, Ireland., Walsh L; Department of Molecular & Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin, Ireland., O'Hurley G; OncoMark Ltd, Belfield Innovation Park, Dublin, Ireland., Mallya Udupi G; OncoMark Ltd, Belfield Innovation Park, Dublin, Ireland., Joseph J; OncoMark Ltd, Belfield Innovation Park, Dublin, Ireland., Tarrant F; UCD School of Biomolecular and Biomedical Science, UCD Conway Institute, University College Dublin, Dublin, Ireland., Conroy E; UCD School of Biomolecular and Biomedical Science, UCD Conway Institute, University College Dublin, Dublin, Ireland., Gaber A; Lund University, Lund, Sweden., Chin SF; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, United Kingdom., Bardwell HA; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, United Kingdom., Provenzano E; Cambridge Experimental Cancer Medicine Centre (ECMR) and NIHR Cambridge Biomedical Research Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom., Crown J; Department of Medical Oncology, St. Vincent's University Hospital, Dublin, Ireland., Dubois T; Institut Curie, PSL Research University, Department of Translational Research, Breast Cancer Biology Group, Paris, France., Linn S; The Netherlands Cancer Institute, Amsterdam, the Netherlands., Jirstrom K; Lund University, Lund, Sweden., Caldas C; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, United Kingdom., O'Connor DP; Department of Molecular & Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin, Ireland., Gallagher WM; UCD School of Biomolecular and Biomedical Science, UCD Conway Institute, University College Dublin, Dublin, Ireland. william.gallagher@ucd.ie.; OncoMark Ltd, Belfield Innovation Park, Dublin, Ireland.
Publikováno v:
Cancer research [Cancer Res] 2017 Jul 15; Vol. 77 (14), pp. 3834-3845. Date of Electronic Publication: 2017 Apr 28.
Autor:
Pereira B, Chin SF, Rueda OM, Vollan HK, Provenzano E, Bardwell HA, Pugh M, Jones L, Russell R, Sammut SJ, Tsui DW, Liu B, Dawson SJ, Abraham J, Northen H, Peden JF, Mukherjee A, Turashvili G, Green AR, McKinney S, Oloumi A, Shah S, Rosenfeld N, Murphy L, Bentley DR, Ellis IO, Purushotham A, Pinder SE, Børresen-Dale AL, Earl HM, Pharoah PD, Ross MT, Aparicio S, Caldas C
Publikováno v:
Nature communications [Nat Commun] 2016 Jun 06; Vol. 7, pp. 11908. Date of Electronic Publication: 2016 Jun 06.
Autor:
Pereira B; Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK.; Department of Oncology, University of Cambridge, Cambridge CB2 2QQ, UK., Chin SF; Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK.; Department of Oncology, University of Cambridge, Cambridge CB2 2QQ, UK., Rueda OM; Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK.; Department of Oncology, University of Cambridge, Cambridge CB2 2QQ, UK., Vollan HK; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Montebello, Oslo 0310, Norway.; The K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo 0318, Norway., Provenzano E; Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre, Cambridge CB2 2QQ, UK.; Cambridge Experimental Cancer Medicine Centre, Cambridge University Hospitals NHS, Hills Road, Cambridge CB2 0QQ, UK., Bardwell HA; Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK., Pugh M; Inivata, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK., Jones L; Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre, Cambridge CB2 2QQ, UK.; Cambridge Experimental Cancer Medicine Centre, Cambridge University Hospitals NHS, Hills Road, Cambridge CB2 0QQ, UK., Russell R; Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK., Sammut SJ; Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK.; Department of Oncology, University of Cambridge, Cambridge CB2 2QQ, UK., Tsui DW; Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK., Liu B; Department of Oncology, University of Cambridge, Cambridge CB2 2QQ, UK., Dawson SJ; Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK.; Peter MacCallum Cancer Centre, Melbourne, Victoria 3002, Australia., Abraham J; Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre, Cambridge CB2 2QQ, UK.; Cambridge Experimental Cancer Medicine Centre, Cambridge University Hospitals NHS, Hills Road, Cambridge CB2 0QQ, UK., Northen H; Illumina, Chesterford Research Park, Little Chesterford, Essex CB10 1XL, UK., Peden JF; Illumina, Chesterford Research Park, Little Chesterford, Essex CB10 1XL, UK., Mukherjee A; Division of Cancer and Stem Cells, School of Medicine, University of Nottingham and Nottingham University Hospital NHS Trust, Nottingham NG5 1PB, UK., Turashvili G; Department of Pathology and Molecular Medicine, Queen's University/Kingston General Hospital, 76 Stuart Street, Kingston, Ontario, Canada K7L 2V7., Green AR; Division of Cancer and Stem Cells, School of Medicine, University of Nottingham and Nottingham University Hospital NHS Trust, Nottingham NG5 1PB, UK., McKinney S; Department of Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada V5Z 1L3., Oloumi A; Department of Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada V5Z 1L3., Shah S; Department of Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada V5Z 1L3., Rosenfeld N; Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK., Murphy L; Research Institute in Oncology and Hematology, 675 McDermot Avenue, Winnipeg, Mannitoba, Canada R3E 0V9., Bentley DR; Illumina, Chesterford Research Park, Little Chesterford, Essex CB10 1XL, UK., Ellis IO; Division of Cancer and Stem Cells, School of Medicine, University of Nottingham and Nottingham University Hospital NHS Trust, Nottingham NG5 1PB, UK., Purushotham A; NIHR Comprehensive Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and Research Oncology, Cancer Division, King's College London, London SE1 9RT, UK., Pinder SE; NIHR Comprehensive Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and Research Oncology, Cancer Division, King's College London, London SE1 9RT, UK., Børresen-Dale AL; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Montebello, Oslo 0310, Norway.; The K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo 0318, Norway., Earl HM; Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre, Cambridge CB2 2QQ, UK.; Cambridge Experimental Cancer Medicine Centre, Cambridge University Hospitals NHS, Hills Road, Cambridge CB2 0QQ, UK., Pharoah PD; Strangeways Research Laboratory, University of Cambridge, 2 Worts' Causeway, Cambridge CB1 8RN, UK., Ross MT; Illumina, Chesterford Research Park, Little Chesterford, Essex CB10 1XL, UK., Aparicio S; Department of Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada V5Z 1L3., Caldas C; Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK.; Department of Oncology, University of Cambridge, Cambridge CB2 2QQ, UK.; Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre, Cambridge CB2 2QQ, UK.; Cambridge Experimental Cancer Medicine Centre, Cambridge University Hospitals NHS, Hills Road, Cambridge CB2 0QQ, UK.
Publikováno v:
Nature communications [Nat Commun] 2016 May 10; Vol. 7, pp. 11479. Date of Electronic Publication: 2016 May 10.
Autor:
Michaut M; Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands., Chin SF; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK., Majewski I; Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands., Severson TM; Division of Molecular Pathology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands., Bismeijer T; Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands., de Koning L; Translational Research Department, Institut Curie, 26 rue d'Ulm, 75248 Paris cedex 05, France., Peeters JK; Agendia NV, Science Park 406, 1098 XH Amsterdam, The Netherlands., Schouten PC; Division of Molecular Pathology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands., Rueda OM; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK., Bosma AJ; Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands., Tarrant F; Cancer Biology and Therapeutics Laboratory, UCD School of Biomolecular and Biomedical Science, UCD Conway Institute, University College Dublin, Belfield, Dublin 4, Ireland.; OncoMark Limited, NovaUCD, Belfield Innovation Park, Dublin 4, Ireland., Fan Y; Cancer Biology and Therapeutics Laboratory, UCD School of Biomolecular and Biomedical Science, UCD Conway Institute, University College Dublin, Belfield, Dublin 4, Ireland., He B; Translational Research Department, Institut Curie, 26 rue d'Ulm, 75248 Paris cedex 05, France., Xue Z; Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands., Mittempergher L; Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands., Kluin RJ; Genomic Core Facility, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands., Heijmans J; Agendia NV, Science Park 406, 1098 XH Amsterdam, The Netherlands., Snel M; Agendia NV, Science Park 406, 1098 XH Amsterdam, The Netherlands., Pereira B; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK., Schlicker A; Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands., Provenzano E; Cambridge Experimental Cancer Medicine Centre (ECMR) and NIHR Cambridge Biomedical Research Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK.; Cambridge Breast Unit and Cambridge University Hospitals, NHS Foundation Trust, Hills Road, Cambridge CB2 0QQ, UK., Ali HR; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK.; Department of Pathology, University of Cambridge, Tennis Court Road, Cambridge, CB2 1QP, UK., Gaber A; Department of Clinical Sciences Lund, Division of Oncology and Pathology, Lund University, SE-221 85 Lund, Sweden., O'Hurley G; OncoMark Limited, NovaUCD, Belfield Innovation Park, Dublin 4, Ireland., Lehn S; Department of Clinical Sciences Lund, Division of Oncology and Pathology, Lund University, SE-221 85 Lund, Sweden., Muris JJ; Division of Molecular Pathology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands., Wesseling J; Division of Molecular Pathology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands., Kay E; Department of Pathology, RCSI ERC, Beaumont Hospital, Dublin 9, Ireland., Sammut SJ; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK., Bardwell HA; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK., Barbet AS; Translational Research Department, Institut Curie, 26 rue d'Ulm, 75248 Paris cedex 05, France., Bard F; Translational Research Department, Institut Curie, 26 rue d'Ulm, 75248 Paris cedex 05, France., Lecerf C; Translational Research Department, Institut Curie, 26 rue d'Ulm, 75248 Paris cedex 05, France., O'Connor DP; Cancer Biology and Therapeutics Laboratory, UCD School of Biomolecular and Biomedical Science, UCD Conway Institute, University College Dublin, Belfield, Dublin 4, Ireland., Vis DJ; Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands., Benes CH; Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, Massachusetts 02129, USA., McDermott U; Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK., Garnett MJ; Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK., Simon IM; Agendia NV, Science Park 406, 1098 XH Amsterdam, The Netherlands., Jirström K; Department of Clinical Sciences Lund, Division of Oncology and Pathology, Lund University, SE-221 85 Lund, Sweden., Dubois T; Translational Research Department, Institut Curie, 26 rue d'Ulm, 75248 Paris cedex 05, France., Linn SC; Division of Molecular Pathology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands.; Division of Medical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands.; Department of Pathology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands., Gallagher WM; Cancer Biology and Therapeutics Laboratory, UCD School of Biomolecular and Biomedical Science, UCD Conway Institute, University College Dublin, Belfield, Dublin 4, Ireland.; OncoMark Limited, NovaUCD, Belfield Innovation Park, Dublin 4, Ireland., Wessels LF; Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands.; Department of EEMCS, Delft University of Technology, Delft, The Netherlands., Caldas C; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK.; Cambridge Experimental Cancer Medicine Centre (ECMR) and NIHR Cambridge Biomedical Research Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK.; Cambridge Breast Unit and Cambridge University Hospitals, NHS Foundation Trust, Hills Road, Cambridge CB2 0QQ, UK.; Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 0QQ, UK., Bernards R; Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands.; Agendia NV, Science Park 406, 1098 XH Amsterdam, The Netherlands.; Cancer Genomics Netherlands, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands.
Publikováno v:
Scientific reports [Sci Rep] 2016 Jan 05; Vol. 6, pp. 18517. Date of Electronic Publication: 2016 Jan 05.